Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | LPL | P06858 | 1/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.40 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12306511 | 0.94 | PDK2 (0.52) | PDK2ADORA1KCNH2PGRLPL | |
| SCHEMBL12306535 | 0.93 | PDK2 (0.52) | PDK2ADORA1KCNH2PGRLPL | |
| SCHEMBL10014418 | 0.88 | PDK2 (0.57) | PDK2ADORA1KCNH2PGRLPL | |
| SCHEMBL12306539 | 0.88 | PDK2 (0.48) | PDK2ADORA1KCNH2PGRLPL | |
| SCHEMBL24293168 | 0.88 | PDK2 (0.51) | PDK2ADORA1KCNH2PGRLPL | |
| SCHEMBL15070070 | 0.85 | PDK2 (0.53) | PDK2ADORA1KCNH2PGRALOX5 | |
| SCHEMBL20932508 | 0.84 | PDK2 (0.43) | PDK2ADORA1KCNH2PGRLPL | |
| SCHEMBL12306546 | 0.83 | PDK2 (0.46) | PDK2 | |
| SCHEMBL6365284 | 0.83 | PDK2 (0.48) | PDK2ADORA1KCNH2PGRLPL | |
| SCHEMBL30297640 | 0.82 | PDK2 (0.53) | PDK2PGRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8013160-B2 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-8013160-B2 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20100277063-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| US-20100277063-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-11-04 | — | — | US | disclosed |
| US-7781628-B2 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-08-24 | — | — | US | disclosed |
| US-7781628-B2 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-08-24 | — | — | US | disclosed |
| US-7683225-B2 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-03-23 | — | — | US | disclosed |
| US-7683225-B2 | Fluorene-based derivative and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-03-23 | — | — | US | disclosed |
| US-20080303433-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
| US-20080303433-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100277063-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | LEF1, FLNA, AFF2 | PDK2 1028/4885ADORA1 4070/4885KCNH2 43/4885 |
| US-20080303433-A1 | FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | FLNA, AFF2, LEF1 | PDK2 933/4885ADORA1 4009/4885KCNH2 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.